tiprankstipranks
Trending News
More News >
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market

Compare ARS Pharmaceuticals (SPRY) vs. Competitors

Compare
564 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
ARS Pharmaceuticals
$8.17
$811.26M
-6.70
-42.91%
3 Buy
0 Hold
0 Sell
Strong Buy
Trevi Therapeutics
$13.47
$1.36B
-42.49
60.51%
7 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$11.16
$1.12B
-5.55
48.60%
10 Buy
0 Hold
0 Sell
Strong Buy
Pharming Group
$15.36
$1.10B
440.65
74.84%
2 Buy
0 Hold
0 Sell
Moderate Buy
Maze Therapeutics, Inc.
$48.03
$2.31B
-9.86
301.59%
10 Buy
0 Hold
0 Sell
Strong Buy
Sionna Therapeutics, Inc.
$36.39
$1.64B
-20.11
162.18%
6 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
SPRY
ARS Pharmaceuticals
8.17
-4.72
-36.62%
TRVI
Trevi Therapeutics
10.61
4.21
65.78%
ORIC
Oric Pharmaceuticals
11.16
3.79
51.42%
PHAR
Pharming Group
15.36
6.53
73.89%
MAZE
Maze Therapeutics, Inc.
48.03
36.17
304.97%
SION
Sionna Therapeutics, Inc.
36.39
24.29
200.74%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts